Antimicrobial photodynamic therapy to oral candidiasis not responsive to micafungin in a patient undergoing hematopoietic cell transplantation

Photodiagnosis Photodyn Ther. 2021 Jun:34:102296. doi: 10.1016/j.pdpdt.2021.102296. Epub 2021 Apr 15.

Abstract

In hematopoietic cell transplants (HCT) patients, opportunistic fungal infections - especially candidiasis - are typical and, due to the immunosuppressed condition, severe and fatal clinical conditions may occur. Many antifungal agents are used for treating candidiasis; however, there are non-responsive, drug-resistant cases in which alternative antimicrobial therapies are strongly needed. The present study aimed to report a clinical case in which antimicrobial photodynamic therapy (aPDT) was used for extensive oral pseudomembranous candidiasis not responsive to micafungin in a patient undergoing HCT. Thus, 0.01 % methylene blue solution was applied for 3 min onto the infected area, followed by 660-nm laser irradiation. Within 72 h, there was neither a symptom nor a sign of the fungal infection. According to the current case report, aPDT seems to be highly effective for HCT patients presenting oral candidiasis not responsive to micafungin; however, further studies are necessary.

Keywords: Cancer patient; Oral candidiasis; Photodynamic therapy.

Publication types

  • Case Reports

MeSH terms

  • Anti-Infective Agents* / therapeutic use
  • Antifungal Agents / therapeutic use
  • Candidiasis, Oral* / drug therapy
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Micafungin / therapeutic use
  • Photochemotherapy* / methods
  • Photosensitizing Agents / therapeutic use

Substances

  • Anti-Infective Agents
  • Antifungal Agents
  • Photosensitizing Agents
  • Micafungin